Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 746 | 556 | 2,128 | 883 | 748 |
| Gross Profit | 746 | 556 | 2,128 | 883 | 748 |
| Operating Expenses | 10,658 | 8,636 | 11,765 | 8,573 | 6,707 |
| Operating Income | -9,912 | -8,080 | -9,637 | -7,690 | -5,959 |
| Other Income | 8 | 7 | 7 | 8 | 11 |
| Pre-tax Income | -9,904 | -8,073 | -9,630 | -7,682 | -5,948 |
| Net Income Continuous | -9,904 | -8,073 | -9,630 | -7,682 | -5,948 |
| Net Income | $-9,904 | $-8,073 | $-9,630 | $-7,682 | $-5,948 |
| EPS Basic Total Ops | -4.00 | -3.40 | -3.80 | -3.20 | -2.40 |
| EPS Basic Continuous Ops | -4.01 | -3.27 | -3.90 | -3.11 | -2.42 |
| EPS Diluted Total Ops | -4.00 | -3.40 | -3.80 | -3.20 | -2.40 |
| EPS Diluted Continuous Ops | -4.01 | -3.27 | -3.90 | -3.11 | -2.42 |
| EBITDA(a) | $-9,912 | $-8,080 | $-9,637 | $-7,690 | $-5,959 |